RCM Technologies, Inc. Announces Second-Quarter Results


PENNSAUKEN, N.J., Aug. 10, 2022 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced engineering, specialty health care, and information technology services, today announced financial results for the thirteen and twenty-six weeks ended July 2, 2022.

RCM Technologies reported revenue of $74.3 million for the thirteen weeks ended July 2, 2022 (the current period), an increase of 51.9% compared to $48.9 million for the thirteen weeks ended July 3, 2021 (the comparable prior-year period). Gross profit was $21.7 million for the current period, a 76.8% increase compared to $12.3 million for the comparable prior-year period.  The Company experienced GAAP operating income of $8.2 million for the current period compared to $1.9 million for the comparable prior-year period.  The Company experienced GAAP net income of $6.0 million, or $0.57 per diluted share, for the current period compared to $1.3 million, or $0.11 per diluted share, for the comparable prior-year period. The Company experienced adjusted EBITDA of $8.4 million for the current period compared to $2.2 million for the comparable prior-year period.

RCM Technologies reported revenue of $156.3 million for the twenty-six weeks ended July 2, 2022 (the current period), an increase of 67.2% compared to $93.5 million for the twenty-six weeks ended July 3, 2021 (the comparable prior-year period). Gross profit was $45.1 million for the current period, a 95.1% increase compared to $23.1 million for the comparable prior-year period.  The Company experienced GAAP operating income of $17.2 million for the current period compared to $3.3 million for the comparable prior-year period.  The Company experienced GAAP net income of $12.5 million, or $1.18 per diluted share, for the current period compared to $2.3 million, or $0.19 per diluted share, for the comparable prior-year period. The Company experienced adjusted EBITDA of $17.7 million for the current period compared to $3.9 million for the comparable prior-year period.

Bradley Vizi, Executive Chairman of RCM Technologies, commented, “I am pleased to announce strong performance throughout the company as we continue to make progress against our long-term strategy. Each unit demonstrated strong execution and performed well in our primarily recession-resistant end markets as demonstrated by year-over-year second-quarter increases of 281% for adjusted EBITDA and 418% for diluted EPS.”

Kevin Miller, Chief Financial Officer of RCM Technologies, commented, “After considering seasonal school closures, our second quarter revenue was consistent with trends experienced in our record-setting first quarter. In addition, we generated operating cash flow of $18.3 million in the second quarter and $20.8 million year-to-date. We anticipate we will continue to see strong results for the balance of fiscal 2022, and now intend to focus on delivering robust growth in fiscal 2023.”

Conference Call
On Thursday, August 11, 2022, RCM Technologies will host a conference call to discuss these results. The call will begin at 11:30 a.m. Eastern Time. The dial-in number is (866) 403-9129.

About RCM
RCM Technologies, Inc. is a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced information technology and engineering services. RCM is an innovative leader in delivering these solutions to commercial and government sectors. RCM is also a provider of specialty healthcare services to major health care institutions and educational facilities. RCM's offices are located in major metropolitan centers throughout North America and Serbia. Additional information can be found at www.rcmt.com.

The statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995. They are subject to various risks, uncertainties, and other factors that could cause the Company’s actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking statements. These statements often include words such as “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “project,” “intend,” “believe,” “plan,” “seek,” “could,” “can,” “should,” “are confident” or similar expressions. In addition, statements that are not historical should also be considered forward-looking statements. These statements are based on assumptions that we have made in light of our experience in the industry, and our perceptions of historical trends, current conditions, expected future developments, and other factors we believe are appropriate in these circumstances. Forward-looking statements include, but are not limited to, those relating to the impact of the COVID-19 pandemic, demand for the Company’s services, expectations regarding our future revenues and other financial results, our pipeline, and potential project wins, and our expectations for growth in our business. Such statements are based on current expectations that involve several known and unknown risks, uncertainties, and other factors, which may cause actual events to be materially different from those expressed or implied by such forward-looking statements. Risk, uncertainties, and other factors may emerge from time to time that could cause the Company’s actual results to differ from those indicated by the forward-looking statements. Investors are directed to consider such risks, uncertainties, and other factors described in documents filed by the Company with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation (and expressly disclaims any such obligation) to update any forward-looking statements contained in this release as a result of new information or future events or developments, except as may be required by law.

RCM Technologies, Inc.Tel: 856.356.4500Corporate Contacts:
2500 McClellan AvenueFax: 856.356.4600Bradley S. Vizi
Pennsauken, NJ 08109info@rcmt.com Executive Chairman
 www.rcmt.com Kevin D. Miller
  Chief Financial Officer

Tables to Follow


RCM Technologies, Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
(In Thousands, Except Per Share Amounts)

 Thirteen Weeks Ended  
 July 2, 2022  July 3, 2021 
Revenue$74,346  $48,933 
Cost of services 52,663   36,667 
Gross profit 21,683   12,266 
Selling, general and administrative 13,264   10,005 
Depreciation and amortization of property and equipment 225   259 
Amortization of acquired intangible assets -   9 
Operating income 8,194   1,943 
Other (income) expense, net (28)  201 
Income before income taxes 8,222   1,742 
Income tax expense 2,208   486 
Net income$6,014  $1,256 
      
Diluted net earnings per share data$0.57  $0.11 


 Twenty-Six Weeks Ended  
 July 2, 2022  July 3, 2021 
Revenue$156,307  $93,482 
Cost of services 111,204   70,366 
Gross profit 45,103   23,116 
Selling, general and administrative 27,411   19,184 
Depreciation and amortization of property and equipment 463   525 
Amortization of acquired intangible assets -   89 
Operating income 17,229   3,318 
Other expense, net 24   213 
Income before income taxes 17,205   3,105 
Income tax expense 4,671   842 
Net income$12,534  $2,263 
      
Diluted net earnings per share data$1.18  $0.19 

RCM Technologies, Inc.
Summary Consolidated Selected Balance Sheet Data
(In Thousands)

 July 2,
2022
 January 1,
2022
 (Unaudited)  
Cash and cash equivalents$3,112 $235
Accounts receivable, net$45,275 $48,240
Total current assets$51,541 $51,971
Total assets$72,425 $72,852
Total current liabilities$33,764 $29,857
Borrowings under line of credit$0 $14,151
Total liabilities$36,133 $46,883
Stockholders’ equity$36,292 $25,969


RCM Technologies, Inc.
Supplemental Operating Results on a Non-GAAP Basis
(Unaudited)
(In Thousands)

The following non-GAAP measures, which adjust for the categories of expenses described below, are non-GAAP financial measures.  Our management believes that these non-GAAP financial measures (“EBITDA” and “Adjusted EBITDA”) are useful information for investors, shareholders, and other stakeholders of our Company in gauging our results of operations on an ongoing basis and to enhance investors’ overall understanding of our current financial performance and period-to-period comparisons.  EBITDA and Adjusted EBITDA should not be considered an alternative to net income as an indicator of performance.  In addition, EBITDA and Adjusted EBITDA do not take into account changes in certain assets and liabilities and interest and income taxes that can affect cash flows.  We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read-only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

The following unaudited table presents the Company’s GAAP net income and the corresponding adjustments used to calculate EBITDA and Adjusted EBITDA for the thirteen and twenty-six weeks ended July 2, 2022 and July 3, 2021. 

 Thirteen Weeks Ended  Twenty-Six Weeks Ended 
 July 2,
2022
  July 3,
2021
  July 2,
2022
  July 3,
2021
 
GAAP net income$6,014  $1,256  $12,534  $2,263 
Income tax expense 2,208   486   4,671   842 
Interest expense 69   122   166   243 
Change in fair value of contingent consideration -   26   -   52 
Depreciation of property and equipment 225   259   463   525 
Amortization of acquired intangible assets -   9   -   89 
EBITDA (non-GAAP)$8,516  $2,158  $17,834  $4,014 
            
Adjustments           
(Gain) loss on foreign currency transactions (97)  53   (142)  (82)
Adjusted EBITDA (non-GAAP)$8,419  $2,211  $17,692  $3,932 



RCM Technologies, Inc.
Summary of Selected Income Statement Data
(Unaudited)
(In Thousands)

 Thirteen Weeks Ended July 2, 2022 
 Engineering  Specialty
Health Care
  Information
Technology
  

Consolidated
 
            
Revenue$20,906  $43,457  $9,983  $74,346 
Cost of services 15,395   30,575   6,693   52,663 
Gross profit$5,511  $12,882  $3,290  $21,683 
Gross profit margin 26.4%  29.6%  33.0%  29.2%


 Thirteen Weeks Ended July 3, 2021 
 Engineering  Specialty
Health Care
  Information
Technology
  

Consolidated
 
            
Revenue$16,934  $22,941  $9,058  $48,933 
Cost of services 12,920   17,349   6,398   36,677 
Gross profit$4,014  $5,592  $2,660  $12,266 
Gross profit margin 23.7%  24.4%  29.4%  25.1%


 Twenty-Six Weeks Ended July 2, 2022 
 Engineering  Specialty
Health Care
  Information
Technology
  

Consolidated
 
            
Revenue$40,804  $95,641  $19,862  $156,307 
Cost of services 30,059   67,758   13,387   111,204 
Gross profit$10,745  $27,883  $6,475  $45,103 
Gross profit margin 26.3%  29.2%  32.6%  28.9%


 Twenty-Six Weeks Ended July 3, 2021 
 Engineering  Specialty
Health Care
  Information
Technology
  

Consolidated
 
            
Revenue$31,400  $44,077  $18,005  $93,482 
Cost of services 24,180   33,448   12,738   70,366 
Gross profit$7,220  $10,629  $5,267  $23,116 
Gross profit margin 23.0%  24.1%  29.3%  24.7%


RCM Technologies, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(In Thousands)

 Thirteen Weeks Ended  
 July 2,
2022
  July 3,
2021
 
Net income$6,014  $1,256 
Adjustments to reconcile net income to cash
used in operating activities
 449   1,356 
Changes in operating assets and liabilities:     
 Accounts receivable 13,779   8,059 
 Prepaid expenses and other current assets 343   1,178 
 Net of transit accounts receivable and payable (731)  1,681 
 Accounts payable and accrued expenses 389   1,616 
 Accrued payroll and related costs (2,392)  (248)
 Right of use liabilities (382)  (489)
 Income taxes payable 1,111   93 
 Deferred revenue (315)  913 
 Deposits 9   6 
Total adjustments 12,260   14,165 
Net cash provided by operating activities$18,274  $15,421 
      
Net cash used in investing activities (223)  (123)
Net cash used in financing activities (15,563)  (14,639)
Effect of exchange rate changes (235)  62 
Increase in cash and cash equivalents$2,253  $721 


 Twenty-Six Weeks Ended  
 July 2,
2022
  July 3,
2021
 
Net income$12,534  $2,263 
Adjustments to reconcile net income to cash
used in operating activities
 1,186   2,533 
Changes in operating assets and liabilities:     
 Accounts receivable 3,565   (1,066)
 Prepaid expenses and other current assets 434   1,676 
 Net of transit accounts receivable and payable (210)  (121)
 Accounts payable and accrued expenses (585)  1,663 
 Accrued payroll and related costs 3,048   (231)
 Right of use liabilities (926)  (988)
 Income taxes payable 2,935   8 
 Deferred revenue (1,237)  578 
 Deposits 11   6 
Total adjustments 8,221   4,058 
Net cash provided by operating activities$20,755  $6,321 
      
Net cash used in investing activities (453)  (182)
Net cash used in financing activities (17,175)  (5,424)
Effect of exchange rate changes (250)  (50)
Increase in cash and cash equivalents$2,877  $665